This is an observational study.
Sponsors
Ministry of Health, Labour and Welfare, Japan, Instituto de Investigación Marqués de Valdecilla, AskBio Inc, Haiyan Pan, There is no funding. This is a investigator-driven study.
Conditions
Atrial FibrillationCardiorenal Syndrome (CRS)Multiple System AtrophyMultiple System Atrophy, Parkinson VariantNon-alcoholic Fatty Liver Disease (NAFLD)Parkinson's DiseaseStroke, Acutekidney transplantation
Unknown Phase
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
NCT01581502
Start: 2011-09-30End: 2016-12-31Target: 1000Updated: 2015-09-02
ABO-incompatible kidney transplantation in The Netherlands.
Active, not recruitingNL-OMON27246
Start: 2019-03-05Target: 10000Updated: 2024-02-28
Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.
NCT04099147
Start: 2019-09-30End: 2020-12-31Target: 14046Updated: 2019-09-23
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
CompletedNCT05699460
Start: 2022-09-29End: 2025-11-04Updated: 2026-07-27
Screening of Predictive Biomarkers for Cardiorenal Syndrome
RecruitingNCT07139626
Start: 2025-09-15End: 2027-12-31Target: 150Updated: 2026-02-27